In the preceding three months, 16 analysts have released ratings for Comerica CMA, presenting a wide array of perspectives from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 1 | 4 | 8 | 3 | 0 |
| Last 30D | 0 | 1 | 2 | 2 | 0 |
| 1M Ago | 1 | 1 | 3 | 1 | 0 |
| 2M Ago | 0 | 2 | 2 | 0 | 0 |
| 3M Ago | 0 | 0 | 1 | 0 | 0 |
Insights from analysts' 12-month price targets are revealed, presenting an average target of $63.62, a high estimate of $75.00, and a low estimate of $51.00. This upward trend is apparent, with the current average reflecting a 13.36% increase from the previous average price target of $56.12.
Interpreting Analyst Ratings: A Closer Look
The analysis of recent analyst actions sheds light on the perception of Comerica by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Brandon King | Truist Securities | Raises | Hold | $70.00 | $66.00 |
| Mike Mayo | Wells Fargo | Raises | Underweight | $51.00 | $43.00 |
| Terry McEvoy | Stephens & Co. | Raises | Overweight | $70.00 | $64.00 |
| Anthony Elian | JP Morgan | Raises | Neutral | $70.00 | $65.00 |
| Jason Goldberg | Barclays | Raises | Underweight | $66.00 | $56.00 |
| Steven Alexopoulos | JP Morgan | Raises | Neutral | $65.00 | $57.00 |
| Ryan Nash | Goldman Sachs | Raises | Buy | $63.00 | $55.00 |
| Ebrahim Poonawala | B of A Securities | Lowers | Underperform | $52.00 | $55.00 |
| John Pancari | Evercore ISI Group | Raises | In-Line | $64.00 | $58.00 |
| Manan Gosalia | Morgan Stanley | Raises | Equal-Weight | $63.00 | $61.00 |
| David Chiaverini | Wedbush | Raises | Outperform | $75.00 | $52.00 |
| Brandon King | Truist Securities | Raises | Hold | $66.00 | $53.00 |
| Terry McEvoy | Stephens & Co. | Maintains | Overweight | $58.00 | $58.00 |
| Peter Winter | DA Davidson | Maintains | Neutral | $55.00 | $55.00 |
| Christopher Mcgratty | Keefe, Bruyette & Woods | Raises | Outperform | $69.00 | $50.00 |
| Manan Gosalia | Morgan Stanley | Raises | Equal-Weight | $61.00 | $50.00 |
Key Insights:
- Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Comerica. This information offers a snapshot of how analysts perceive the current state of the company.
- Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Comerica compared to the broader market.
- Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Comerica's stock. This examination reveals shifts in analysts' expectations over time.
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Comerica's market position. Stay informed and make well-informed decisions with our Ratings Table.
Stay up to date on Comerica analyst ratings.
Unveiling the Story Behind Comerica
With assets of around $80 billion, Comerica is primarily a relationship-based commercial bank headquartered in Dallas. In addition to Texas, Comerica's other primary geographies are California and Michigan, with locations also in Arizona and Florida and select businesses operating in several other states as well as Canada and Mexico.
Comerica: Delving into Financials
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Growth: Comerica's revenue growth over a period of 3 months has faced challenges. As of 30 June, 2024, the company experienced a revenue decline of approximately -10.82%. This indicates a decrease in the company's top-line earnings. When compared to others in the Financials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Comerica's net margin is impressive, surpassing industry averages. With a net margin of 24.27%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Comerica's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 3.5% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Comerica's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 0.25%, the company may face hurdles in achieving optimal financial performance.
Debt Management: With a below-average debt-to-equity ratio of 1.45, Comerica adopts a prudent financial strategy, indicating a balanced approach to debt management.
What Are Analyst Ratings?
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. Click here for urgent details.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
